Olivier Litzka

Olivier joined Andera Partners in 2006.

Olivier holds a PhD in molecular microbiology from University of Munich (LMU). During his scientific work he focused on fundamental and applied sciences relating to molecular regulation mechanisms in antibiotic biosynthesis.

In 1998, Olivier joined Mercer Management Consulting in Munich to work on strategic business projects in the healthcare and other industries, in Europe, the US, and Asia.

Olivier currently serves on the board of MMI Microsystems, T-Knife, Arvelle Therapeutics, Allecra Therapeutics, HighLife Medical, MedLumics, Tricares and JenaValve. He was also a board member of Corvidia, Sapiens, Endosense, Novexel and Supersonic Imagine up until their respective acquisitions by large pharmaceutical or medical device companies.